Ivoxel

Mometasone Furoate, the active ingredient in Ivoxel, is a corticosteroid (glucocorticoid) presented as a topical formulation for skin application. It treats inflammatory and allergic skin disorders such as psoriasis, atopic dermatitis, and contact dermatitis in both adults and children as prescribed.

GNH USA supplies Ivoxel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ivoxel, a topical glucocorticoid, is used to manage inflammatory skin conditions by reducing redness, swelling and itching. - Psoriasis: helps clear plaques and reduces scaling. - Atopic dermatitis (eczema): alleviates itching and inflammation. - Contact dermatitis: diminishes allergic skin reactions. - Other inflammatory skin disorders: provides anti‑inflammatory relief for various dermatitis types.

Topical application of Mometasone Furoate may cause local and, rarely, systemic adverse reactions.

Common Side Effects: - Burning or stinging at the application site. - Itching or dryness of the skin. - Erythema or mild redness. - Folliculitis or acneiform eruptions. - Skin irritation or contact dermatitis.

Serious or Rare Side Effects: - Skin atrophy or thinning. - Telangiectasia (visible small blood vessels). - Hypopigmentation or depigmentation. - Systemic adrenal suppression with extensive use. - Secondary bacterial, fungal or viral skin infections. - Allergic contact dermatitis to the formulation.

Before using Ivoxel, consider the following safety measures. - Apply only to affected areas: follow the prescriber's instructions. - Avoid prolonged continuous use: risk of skin thinning and systemic effects. - Do not use on broken skin or open wounds: may increase systemic absorption. - Limit use on face, groin, and axillae: higher risk of local side effects. - Use with caution in children: larger surface‑area‑to‑body‑mass ratio. - Store at room temperature: keep in the original pack, protect from moisture and light.

Topical corticosteroids can interact with other agents, requiring attention.

Major Interactions (Avoid): - Systemic corticosteroids: additive immunosuppressive effects may increase infection risk. - Potent CYP3A4 inhibitors applied nearby: may raise systemic exposure of mometasone.

Moderate Interactions (Monitor Closely):\n- Antifungal or antibacterial creams used on the same area: potential for irritation or reduced efficacy. - Live vaccines administered systemically: possible reduced vaccine response if significant systemic absorption occurs. - Other topical immunosuppressants: may enhance local immunosuppression and infection risk.